MedTrace Logo

Oxytocin and the Processing of Social Stress-Associated Chemosignals

NCT03265899 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether oxytocin modulates the processing of stress-associated chemosignals and which substrates are involved.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Oxytocin

40 IU; 5 puffs balanced across nostrils, at an inter-puff interval of 30 seconds

DRUG

Placebo

Placebo nasal spray, 5 puffs balanced across nostrils, at an inter-puff interval of 30 seconds

Sponsors & Collaborators

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Rene Hurlemann, MSc MD PhD · Department of Psychiatry, University of Bonn, Germany

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2016-11-30
Completion
2016-11-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03265899 on ClinicalTrials.gov